Infectious Disease

Globally, human lifespans have been increasing in large part due to advances in treating and eliminating infectious diseases. Yet, the threat from emerging, reemerging and entrenched infectious diseases remains a challenge for society. Traditional methodology has had success in the past, but with an ever-globalizing world, the need for fast, accurate and comprehensive research is paramount. Partnering with international collaborators is enabling JCVI to be the catalyst for better understanding and potential new treatments against the scourge of infectious disease.


SARS-CoV-2 Mutation Tracking

Press Release

J. Craig Venter Institute Scientists to Investigate Role of Opioid Abuse in HIV and HIV-Associated Neurocognitive Disorders Pathogenesis through $4.7M NIDA Grant

Study aims to identify candidate molecules to regulate HIV infection in the central nervous system in patients abusing opioids

The San Diego Union Tribune

Scientists rush to determine if mutant strain of coronavirus will deepen pandemic

U.S. researchers have been slow to perform the genetic sequencing that will help clarify the situation

Press Release

J. Craig Venter Institute and UC San Diego Develop Phage Treatment as Potential Cure for Alcoholic Liver Disease

Team targeted specific toxin-producing strains of the bacterium, Enterococcus faecalis, which is shown to be responsible for most liver damage

Collaborator Release

Combining Antibiotics, Researchers Deliver One-Two Punch against Ubiquitous Bacterium

CWRU/Cleveland VA findings in mouse models could make inroads against superbugs


Fighting Back Against Flu

Collaborator Release

Past encounters with the flu shape vaccine response

Immune history influences vaccine effectiveness, interacting with other potential problems arising from the manufacturing process